Prelude Therapeutics prices $90 million stock offering at $4.44 per share Apr 20, 2026 06:31AM
Prelude Therapeutics Announces Pricing of $90.0 Million Underwritten Offering Apr 20, 2026 06:30AM
Prelude Therapeutics to Participate in Citizens JMP Securities Hematology and Oncology Summit Nov 27, 2024 07:30AM
JMP Securities Starts Prelude Therapeutics (PRLD) at Market Outperform, 'Precision Targeting of SMARCA Drives Cell Kill' Mar 13, 2024 03:56AM
Prelude Therapeutics to Participate in Three Healthcare Investor Conferences in May Apr 27, 2023 08:30AM


Apr 27, 2023 08:30AM Prelude Therapeutics to Participate in Three Healthcare Investor Conferences in May
Jun 2, 2021 07:00AM Prelude Therapeutics Announces Participation at Two Upcoming Virtual Investor Conferences